Skip to main content
Top
Published in: Acta Neuropathologica 2/2003

01-08-2003 | Letter to the Editor

Clinical and neuropathological correlates of Lewy body disease

Authors: Kurt A. Jellinger, Klaus Seppi, Gregor K. Wenning

Published in: Acta Neuropathologica | Issue 2/2003

Login to get access

Excerpt

In a recent clinicopathological study of 30 brains of patients with Lewy body (LB) disease clinically presenting as Parkinson's disease (PD), dementia with Lewy bodies (DLB) or pure autonomic failure (PAF) and morphologically classified as neocortical, limbic and brain-stem predominant types, Hishikawa et al. [8] stated that both the clinical features and the morphological changes, in particular the immunopathological features and distribution of neurological and glial inclusions, were similar. All neocortical cases (n=8, mean age at death 70.2 years, mean duration 8 years) showed parkinsonism and dementia within or more than 1 year after onset of symptoms; limbic type (n=17, mean age 74.7 years, mean duration 9.9 years) had parkinsonism but only 70.6% developed dementia, occasionally with fluctuating cognition, while the brain stem-predominant type either showed parkinsonism (n=1) or PAF (n=2). Because neuritic Alzheimer's disease (AD) pathology in all cases corresponded to Braak stages I or II, none fitted to accepted criteria of additional AD or its LB variant (LBV/AD). Since DLB, PD with and without dementia and PAF shared several clinical and neuropathological feature, the authors concluded that these conditions are part of a unique "LB disease" spectrum. …
Literature
1.
go back to reference Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239–259PubMed Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239–259PubMed
2.
go back to reference Braak H, Del Tredici K, Bratzke H, Hamm-Clement J, Sandmann-Keil D, Rub U (2002) Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages). J Neurol 249 [Suppl 3]:III/1–5 Braak H, Del Tredici K, Bratzke H, Hamm-Clement J, Sandmann-Keil D, Rub U (2002) Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages). J Neurol 249 [Suppl 3]:III/1–5
3.
go back to reference Braak H, Tredici KD, Rub U, Vos RA de, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24:197–211CrossRefPubMed Braak H, Tredici KD, Rub U, Vos RA de, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24:197–211CrossRefPubMed
4.
go back to reference Del Tredici K, Rub U, De Vos RA, Bohl JR, Braak H (2002) Where does parkinson disease pathology begin in the brain? J Neuropathol Exp Neurol 61:413–426 Del Tredici K, Rub U, De Vos RA, Bohl JR, Braak H (2002) Where does parkinson disease pathology begin in the brain? J Neuropathol Exp Neurol 61:413–426
5.
go back to reference Gomez-Isla T, Growdon WB, McNamara M, Newell K, Gomez-Tortosa E, Hedley-Whyte ET, Hyman BT (1999) Clinicopathologic correlates in temporal cortex in dementia with Lewy bodies. Neurology 53:2003–2009PubMed Gomez-Isla T, Growdon WB, McNamara M, Newell K, Gomez-Tortosa E, Hedley-Whyte ET, Hyman BT (1999) Clinicopathologic correlates in temporal cortex in dementia with Lewy bodies. Neurology 53:2003–2009PubMed
6.
go back to reference Hansen LA (1997) The Lewy body variant of Alzheimer disease. J Neural Transm Suppl 51:83–93PubMed Hansen LA (1997) The Lewy body variant of Alzheimer disease. J Neural Transm Suppl 51:83–93PubMed
7.
go back to reference Harding AJ, Halliday GM (2001) Cortical Lewy body pathology in the diagnosis of dementia. Acta Neuropathol 102:355–363PubMed Harding AJ, Halliday GM (2001) Cortical Lewy body pathology in the diagnosis of dementia. Acta Neuropathol 102:355–363PubMed
8.
go back to reference Hishikawa N, Hashizume Y, Yoshida M, Sobue G (2003) Clinical and neuropathological correlates of Lewy body disease. Acta Neuropathol 105:341–350PubMed Hishikawa N, Hashizume Y, Yoshida M, Sobue G (2003) Clinical and neuropathological correlates of Lewy body disease. Acta Neuropathol 105:341–350PubMed
9.
go back to reference Jellinger KA, Seppi K, Wenning GK, Poewe W (2001) Impact of coexitent Alzheimer pathology on the natural history of Parkinson disease and dementia with Lewy bodies. Neuropathol Appl Neurobiol 27:155 Jellinger KA, Seppi K, Wenning GK, Poewe W (2001) Impact of coexitent Alzheimer pathology on the natural history of Parkinson disease and dementia with Lewy bodies. Neuropathol Appl Neurobiol 27:155
10.
go back to reference Jellinger KA, Seppi K, Wenning GK, Poewe W (2002) Impact of coexistent Alzheimer pathology on the natural history of Parkinson's disease. J Neural Transm 109:329–339PubMed Jellinger KA, Seppi K, Wenning GK, Poewe W (2002) Impact of coexistent Alzheimer pathology on the natural history of Parkinson's disease. J Neural Transm 109:329–339PubMed
11.
go back to reference Luginger E, Seppi K, Litvan I, Ransmayer G, Poewe W, Jellinger KA, Wenning GK (2000) Associated Alzheimer pathology modifies the natural history of dementia with Lewy bodies (DLB): a clinicopathological study. Mov Disord 15:226CrossRef Luginger E, Seppi K, Litvan I, Ransmayer G, Poewe W, Jellinger KA, Wenning GK (2000) Associated Alzheimer pathology modifies the natural history of dementia with Lewy bodies (DLB): a clinicopathological study. Mov Disord 15:226CrossRef
12.
go back to reference McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen EN, Ballard C, Vos RA de, Wilcock GK, Jellinger KA, Perry RH (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47:1113–1124PubMed McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen EN, Ballard C, Vos RA de, Wilcock GK, Jellinger KA, Perry RH (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47:1113–1124PubMed
13.
go back to reference Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, Belle G van, Berg L (1991) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41:479–486PubMed Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, Belle G van, Berg L (1991) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41:479–486PubMed
Metadata
Title
Clinical and neuropathological correlates of Lewy body disease
Authors
Kurt A. Jellinger
Klaus Seppi
Gregor K. Wenning
Publication date
01-08-2003
Publisher
Springer-Verlag
Published in
Acta Neuropathologica / Issue 2/2003
Print ISSN: 0001-6322
Electronic ISSN: 1432-0533
DOI
https://doi.org/10.1007/s00401-003-0721-2

Other articles of this Issue 2/2003

Acta Neuropathologica 2/2003 Go to the issue

Letter to the Editor

Reply to K. Jellinger